Literature DB >> 32038790

Methylated Organic Metabolites of Arsenic and their Cardiovascular Toxicities.

Ok-Nam Bae1, Kyung-Min Lim1, Ji-Yoon Noh1, Keun-Young Kim1, Eun-Kyung Lim1, Jin-Ho Chung1.   

Abstract

Recently, arsenic-toxicity has become the major focus of strenuous assessment and dynamic research from the academy and regulatory agency. To elucidate the cause and the mechanism underlying the serious adverse health effects from chronic ingestion of arsenic-contaminated drinking water, numerous studies have been directed on the investigation of arsenic-toxicity using various in vitro as well as in vivo systems. Neverthless, some questions for arsenic effects remain unexplained, reflecting the contribution of unknown factors to the manifestation of arsenic-toxicity. Interestingly, very recent studies on arsenic metabolites have discovered that trivalent methylated arsenicals show stronger cytotoxic and genotoxic potentials than inorganic arsenic or pentavalent metabolites, arguing that these metabolites could play a key role in arsenic-associated disorders. In this review, recent progress and literatures are summarized on the metabolism of trivalent methylated metabolites and their toxicity on body systems including cardiovascular system in an effort to provide an insight into the future research on arsenic-associated disorders. © Korean Society of Toxicology 2008.

Entities:  

Keywords:  Arsenic; DMAIII; MMAIII; Toxicity; Trivalent arsenic metabolite

Year:  2008        PMID: 32038790      PMCID: PMC7006311          DOI: 10.5487/TR.2008.24.3.161

Source DB:  PubMed          Journal:  Toxicol Res        ISSN: 1976-8257


  74 in total

1.  Methylated trivalent arsenic species are genotoxic.

Authors:  M J Mass; A Tennant; B C Roop; W R Cullen; M Styblo; D J Thomas; A D Kligerman
Journal:  Chem Res Toxicol       Date:  2001-04       Impact factor: 3.739

2.  Enhancement of platelet aggregation and thrombus formation by arsenic in drinking water: a contributing factor to cardiovascular disease.

Authors:  Moo-Yeol Lee; Ok-Nam Bae; Seung-Min Chung; Kyu-Tae Kang; Joo-Young Lee; Jin-Ho Chung
Journal:  Toxicol Appl Pharmacol       Date:  2002-03-01       Impact factor: 4.219

3.  Arsenic levels in blood, urine, hair and nails from a chronically exposed human population.

Authors:  A Olguín; P Jauge; M Cebrián; A Albores
Journal:  Proc West Pharmacol Soc       Date:  1983

Review 4.  Arsenic and atherosclerosis.

Authors:  Petia P Simeonova; Michael I Luster
Journal:  Toxicol Appl Pharmacol       Date:  2004-08-01       Impact factor: 4.219

Review 5.  Chronic health effects in people exposed to arsenic via the drinking water: dose-response relationships in review.

Authors:  Takahiko Yoshida; Hiroshi Yamauchi; Gui Fan Sun
Journal:  Toxicol Appl Pharmacol       Date:  2004-08-01       Impact factor: 4.219

Review 6.  An overview on chronic arsenism via drinking water in PR China.

Authors:  Yajuan Xia; Jun Liu
Journal:  Toxicology       Date:  2004-05-20       Impact factor: 4.221

7.  Tissue dosimetry, metabolism and excretion of pentavalent and trivalent dimethylated arsenic in mice after oral administration.

Authors:  Michael F Hughes; Vicenta Devesa; Blakely M Adair; Sean D Conklin; John T Creed; Miroslav Styblo; Elaina M Kenyon; David J Thomas
Journal:  Toxicol Appl Pharmacol       Date:  2007-10-22       Impact factor: 4.219

8.  Arsenite-enhanced procoagulant activity through phosphatidylserine exposure in platelets.

Authors:  Ok-Nam Bae; Kyung-Min Lim; Ji-Yoon Noh; Seung-Min Chung; Heon Kim; Choong-Ryeol Lee; Jung-Duck Park; Jin-Ho Chung
Journal:  Chem Res Toxicol       Date:  2007-10-05       Impact factor: 3.739

9.  Mitochondria work as reactors in reducing arsenate to arsenite.

Authors:  Balázs Németi; Zoltán Gregus
Journal:  Toxicol Appl Pharmacol       Date:  2002-08-01       Impact factor: 4.219

10.  Arsenic: in search of an antidote to a global poison.

Authors:  M Nathaniel Mead
Journal:  Environ Health Perspect       Date:  2005-06       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.